Endonovo Therapeutics Inc (ENDV)

[Craig305]

UNITED STATES OF AMERICA

BEFORE THE

SECURITIES AND EXCHANGE COMMISSION

September 19, 2024
__________________________________

In the Matter of

Endonovo Therapeutics, Inc. 6320 Canoga Avenue, 15th Floor Woodland Hills, CA 91367

ORDER DECLARING OFFERING STATEMENT ABANDONED UNDER THE SECURITIES ACT OF 1933, AS AMENDED

File No: 024-11805
__________________________________

Endonovo Therapeutics, Inc. filed with the Commission an offering statement to qualify an offering of securities under Section 3(b) of the Securities Act of 1933. The offering statement has been on file for more than nine months and has not yet been qualified.

In view of the foregoing, it is ORDERED that the offering statement be declared abandoned on September 19, 2024.

For the Commission, by the Division of Corporation Finance, pursuant to delegated authority.